Robert W. McMahon - 11 Aug 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP & Chief Financial Officer
Signature
/s/ Caitlin Hippeli, as an agent for Robert W. McMahon
Issuer symbol
WST
Transactions as of
11 Aug 2025
Net transactions value
+$3,553,039
Form type
4
Filing time
12 Aug 2025, 19:19:00 UTC
Previous filing
12 Aug 2025
Next filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McMahon Robert W. SVP & Chief Financial Officer 530 HERMAN O. WEST DRIVE, EXTON /s/ Caitlin Hippeli, as an agent for Robert W. McMahon 12 Aug 2025 0001608730

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Rst. Stock Unit Award $0 +12,670 $0.000000 12,670 11 Aug 2025 Common Stock 12,670 $0.000000 Direct F1
transaction WST Rst. Stock Unit Award $0 +3,168 $0.000000 3,168 11 Aug 2025 Common Stock 3,168 $0.000000 Direct F2
transaction WST Stock Option (Right to Buy) Award $1,837,804 +7,647 $240.33 7,647 11 Aug 2025 Common Stock 7,647 $240.33 Direct F2
transaction WST Stock Option (Right to Buy) Award $1,715,235 +7,137 $240.33 7,137 11 Aug 2025 Common Stock 7,137 $240.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in three installments. 4,223 shares will vest six months from the grant date, 6,335 shares will vest 12 months from the grant date, and 2,112 shares will vest 24 months from the grant date.
F2 This award vests in four equal installments beginning on August 11, 2026.